News Medical on MSN14h
Gut microbes influence how well cancer patients respond to immunotherapyResearchers discovered that gut microbiota-derived hexa-acylated LPS enhances the effectiveness of anti-PD-1 cancer ...
BioSkryb Genomics, a Durham company focused on single-cell and ultra-low input multiomics, has introduced a new service called ResolveSEQ MRD, which allows more detailed classification and ...
Stem cell transplants play a vital role in treating people affected by blood cancers and disorders such as thalassemia.
MaxCyte ( NASDAQ: MXCT) Wednesday said that it had entered into a strategic platform license with TG Therapeutics, a fully integrated, commercial-stage, biopharmaceutical company focused on the ...
Under the terms of the agreement, TG Therapeutics obtains non-exclusive research, clinical and commercial rights to use MaxCyte’s Flow Electroporation ® technology and ExPERT™ platform. In return, ...
The global cell counting market, valued at US$10.82 billion in 2023, is forecasted to grow at a robust CAGR of 7.7%, reaching US$11.12 billion ...
This important study demonstrates the potential of synthetic gene circuits to detect and target aberrant RAS activity in cancer cell lines. The circuit design is novel and the evidence supporting the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback